Index S&P 500
P/E 24.13
EPS (ttm) 3.62
Insider Own 0.17%
Shs Outstand 1.28B
Perf Week -0.19%
Market Cap 111.93B
Forward P/E 14.59
EPS next Y 5.98
Insider Trans -1.01%
Shs Float 1.28B
Perf Month 3.58%
Income 4.66B
PEG 4.38
EPS next Q 1.23
Inst Own 85.88%
Short Float 0.62%
Perf Quarter -6.23%
Sales 33.54B
P/S 3.34
EPS this Y 1.05%
Inst Trans 1.66%
Short Ratio 0.99
Perf Half Y 4.41%
Book/sh 37.46
P/B 2.33
EPS next Y 7.81%
ROA 5.13%
Short Interest 7.88M
Perf Year 6.49%
Cash/sh 6.99
P/C 12.48
EPS next 5Y 5.51%
ROE 9.49%
52W Range 75.96 - 96.25
Perf YTD 9.25%
Dividend Est. 2.77 (3.17%)
P/FCF 21.59
EPS past 5Y 0.37%
ROIC 6.33%
52W High -9.33%
Beta 0.81
Dividend TTM 2.80 (3.21%)
Quick Ratio 1.42
Sales past 5Y 3.01%
Gross Margin 67.55%
52W Low 14.89%
ATR (14) 1.47
Dividend Ex-Date Jun 27, 2025
Current Ratio 1.85
EPS Y/Y TTM 31.18%
Oper. Margin 19.44%
RSI (14) 58.26
Volatility 0.91% 1.41%
Employees 95000
Debt/Eq 0.59
Sales Y/Y TTM 3.62%
Profit Margin 13.90%
Recom 2.24
Target Price 93.54
Option/Short Yes / Yes
LT Debt/Eq 0.53
EPS Q/Q 66.19%
Payout 77.56%
Rel Volume 0.78
Prev Close 88.49
Sales Surprise 1.23%
EPS Surprise 2.46%
Sales Q/Q 3.94%
Earnings May 21 BMO
Avg Volume 7.94M
Price 87.27
SMA20 2.54%
SMA50 3.47%
SMA200 0.01%
Trades
Volume 6,011,625
Change -1.38%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-04-25 Upgrade
Citigroup
Neutral → Buy
$92 → $107
Oct-10-24 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$98 → $105
Aug-21-24 Reiterated
Oppenheimer
Perform
$92 → $94
Aug-15-24 Upgrade
UBS
Sell → Neutral
$76 → $90
Aug-14-24 Downgrade
Stifel
Buy → Hold
$100 → $85
May-30-24 Initiated
Goldman
Sell
$83
Jul-19-23 Initiated
Robert W. Baird
Neutral
$90
Jun-30-23 Initiated
CL King
Buy
$106
May-30-23 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$104
Apr-24-23 Upgrade
Wells Fargo
Equal Weight → Overweight
$77 → $100
Mar-29-23 Downgrade
UBS
Buy → Sell
$127 → $79
Jan-09-23 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$102 → $89
Nov-23-22 Downgrade
Oppenheimer
Outperform → Perform
$106 → $85
Nov-23-22 Downgrade
Citigroup
Buy → Neutral
$108 → $85
Nov-16-22 Downgrade
Deutsche Bank
Buy → Hold
$85
Oct-18-22 Initiated
Barclays
Equal Weight
$90
Oct-13-22 Initiated
Mizuho
Buy
$100
Oct-12-22 Initiated
Jefferies
Hold
$87
Aug-24-22 Downgrade
Raymond James
Outperform → Mkt Perform
Jul-06-22 Initiated
Wolfe Research
Underperform
$85
Show Previous Ratings
Jun-13-25 08:56PM
12:09PM
04:45AM
04:25AM
Jun-12-25 09:00AM
06:00AM
Loading…
06:00AM
Jun-11-25 10:25AM
08:29AM
06:20AM
05:00AM
Jun-10-25 08:53AM
05:34AM
Jun-09-25 11:33AM
Jun-06-25 09:33AM
06:42AM
08:00AM
Loading…
Jun-05-25 08:00AM
07:18AM
Jun-04-25 02:36PM
09:04AM
Jun-02-25 05:03PM
Jun-01-25 08:02AM
May-31-25 07:45AM
May-30-25 01:17AM
May-29-25 09:22AM
May-28-25 10:17AM
(Investor's Business Daily)
10:14AM
(Investor's Business Daily)
10:08AM
May-27-25 01:52PM
May-23-25 04:59PM
07:21AM
05:50AM
Loading…
05:50AM
May-22-25 05:41PM
04:55PM
03:00PM
08:05AM
06:05AM
03:03AM
May-21-25 04:49PM
04:00PM
01:23PM
(The Wall Street Journal)
12:46PM
12:36PM
12:03PM
11:37AM
09:39AM
(The Wall Street Journal)
09:30AM
09:10AM
08:51AM
(Investor's Business Daily)
08:51AM
(Investor's Business Daily)
07:55AM
07:04AM
(Associated Press Finance)
06:45AM
06:44AM
05:18AM
May-20-25 02:53PM
May-18-25 12:05PM
05:00AM
May-16-25 10:00AM
(The Wall Street Journal)
09:15AM
08:36AM
07:47AM
May-15-25 08:15PM
06:49AM
May-14-25 05:45PM
10:25AM
May-13-25 04:43PM
May-12-25 05:10PM
04:28PM
May-10-25 08:21AM
May-09-25 06:35AM
May-08-25 05:45PM
03:00PM
07:45AM
07:20AM
May-07-25 06:07PM
03:00PM
10:02AM
May-03-25 09:45AM
May-02-25 05:45PM
Apr-30-25 05:50PM
08:30AM
05:38AM
Apr-29-25 09:30PM
08:07PM
12:30PM
11:10AM
Apr-28-25 11:25PM
07:26AM
07:15AM
05:27AM
Apr-26-25 07:20PM
02:32PM
02:20PM
Apr-25-25 05:45PM
03:00PM
12:26PM
(Nation's Restaurant News)
06:09AM
03:09AM
Apr-24-25 05:45PM
11:50AM
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Salmon Sean Officer Jun 06 '25 Proposed Sale 86.81 18,378 1,595,469 Jun 06 02:43 PM Walter Matthew R. SVP, Chief HR Officer Jan 27 '25 Option Exercise 74.84 1,337 100,061 26,997 Jan 28 05:10 PM Marinaro Michael EVP & President, Surgical OU Jan 27 '25 Option Exercise 74.84 2,345 175,500 43,323 Jan 28 05:09 PM Martha Geoffrey Chairman and CEO Jan 27 '25 Option Exercise 74.84 34,741 2,600,016 216,954 Jan 28 05:07 PM Wall Brett A. EVP & Pres Neuroscience Jan 24 '25 Option Exercise 78.00 12,437 970,086 53,416 Jan 27 05:35 PM Wall Brett A. EVP & Pres Neuroscience Jan 24 '25 Sale 90.00 12,437 1,119,330 40,979 Jan 27 05:35 PM Wall Brett A. Officer Jan 24 '25 Proposed Sale 90.00 12,437 1,119,330 Jan 24 02:34 PM Wall Brett A. EVP & Pres Neuroscience Jan 08 '25 Option Exercise 74.84 6,850 512,654 50,558 Jan 10 04:48 PM Wall Brett A. EVP & Pres Neuroscience Jan 08 '25 Sale 80.41 9,850 792,038 40,708 Jan 10 04:48 PM Wall Brett A. Officer Jan 08 '25 Proposed Sale 80.41 9,850 792,038 Jan 08 09:52 AM PARKHILL KAREN L Former Director Oct 31 '24 Proposed Sale 89.73 30,000 2,691,794 Oct 31 03:21 PM PARKHILL KAREN L Former Director Oct 30 '24 Proposed Sale 90.58 15,000 1,358,740 Oct 30 04:11 PM PARKHILL KAREN L Former BOD Oct 29 '24 Proposed Sale 91.16 15,000 1,367,348 Oct 29 03:26 PM PARKHILL KAREN L Former Director Oct 24 '24 Proposed Sale 92.49 22,712 2,100,633 Oct 24 04:01 PM PARKHILL KAREN L Former Director Oct 23 '24 Proposed Sale 91.76 23,848 2,188,205 Oct 23 04:30 PM PARKHILL KAREN L Former BOD Oct 18 '24 Proposed Sale 91.74 48,825 4,479,310 Oct 18 04:24 PM PARKHILL KAREN L Former BOD Oct 17 '24 Proposed Sale 89.87 55,179 4,958,718 Oct 17 03:35 PM PARKHILL KAREN L Former Officer Aug 26 '24 Proposed Sale 90.00 2,668 240,120 Aug 26 02:11 PM Wall Brett A. EVP & Pres Neuroscience Aug 02 '24 Option Exercise 0.00 5,311 0 49,169 Aug 06 06:16 PM Walter Matthew R. SVP, Chief HR Officer Aug 02 '24 Option Exercise 0.00 684 0 25,889 Aug 06 06:15 PM Smith Gregory L EVP Global Ops & Supply Chain Aug 02 '24 Option Exercise 0.00 3,490 0 64,757 Aug 06 06:14 PM Salmon Sean EVP & President Cardiovascular Aug 02 '24 Option Exercise 0.00 5,462 0 68,546 Aug 06 06:14 PM PARKHILL KAREN L EVP & Chief Financial Officer Aug 02 '24 Option Exercise 0.00 7,132 0 53,459 Aug 06 06:13 PM Martha Geoffrey Chairman and CEO Aug 02 '24 Option Exercise 0.00 18,966 0 203,086 Aug 06 06:13 PM Marinaro Michael EVP & President, Surgical OU Aug 02 '24 Option Exercise 0.00 1,670 0 43,801 Aug 06 06:12 PM Kirk Jennifer M Chief Accounting Officer Aug 02 '24 Option Exercise 0.00 1,138 0 28,980 Aug 06 06:12 PM Fong Ivan K EVP GENERAL COUNSEL & SECR Aug 02 '24 Option Exercise 0.00 14,514 0 63,750 Aug 06 06:11 PM Walter Matthew R. SVP, Chief HR Officer Jul 18 '24 Option Exercise 62.76 492 30,878 17,580 Jul 19 04:40 PM